Consistent with this hypothesis, we observed that Drp1 inhibition with mDivi-1 potentiated the toxicity of SMAC mimetics in ovarian, lung, breast, and melanoma cell lines (Supplementary Fig. 3d–f). Here, DNM1L is linked to melanoma.